Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Eclinicalmedicine|July 12, 2023
Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platformRuth E Costello, John Tazare, Dominik Piehlmaier, et al.
The Lancet Regional Health. Europe|November 6, 2023
Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platformBang Zheng, John Tazare, Linda Nab, et al.
BMJ Open|January 31, 2023
Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study, Edward Pk Parker, John Tazare, et al.
The Lancet Regional Health. Europe|September 15, 2025
Long-term kidney outcomes after COVID-19: a matched cohort study using the OpenSAFELY platformViyaasan Mahalingasivam, Bang Zheng, Kevin Wing, et al.
BMJ Open|October 16, 2024
Impacts of the COVID-19 pandemic on deprivation-level differences in cardiovascular hospitalisations: a comparison of England and Denmark using the OpenSAFELY platform and National Registry DataRuth E Costello, Lars Pedersen, Alasdair D Henderson, et al.
ERJ Open Research|February 23, 2023
Characteristics and risk factors for post-COVID-19 breathlessness after hospitalisation for COVID-19Luke Daines, Bang Zheng, Omer Elneima, et al.
BMJ (Clinical Research Ed.)|November 17, 2022
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platformBang Zheng, Amelia C A Green, John Tazare, et al.
The Lancet. Public Health|April 29, 2023
Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platformLinda Nab, Edward P K Parker, Colm D Andrews, et al.
The Lancet Regional Health. Europe|June 1, 2023
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controlsBang Zheng, Giulia Vivaldi, Luke Daines, et al.
BMJ Medicine|March 20, 2023
Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELYAmelia C A Green, Helen J Curtis, Rose Higgins, et al.
Pageof 10